 |
|
Hyperhomocystinemia
A Risk Factor or a Consequence of Coronary Heart Disease?
Paul Knekt, PhD;
Antti Reunanen, MD, PhD;
Georg Alfthan, PhD;
Markku Heliövaara, MD, PhD;
Harri Rissanen;
Jukka Marniemi, PhD;
Arpo Aromaa, MD, PhD
Arch Intern Med. 2001;161:1589-1594.
Background Mild hyperhomocystinemia has been suggested as an indicator of an increased
risk of cardiovascular disease.
Objective To examine whether serum homocysteine concentration is a predictor of
coronary heart disease (CHD) events.
Methods A case-control study, nested in a population-based cohort study was
used. During a follow-up of 13 years, 166 major coronary events (death from
CHD or nonfatal myocardial infarction) occurred in men with evidence of heart
disease at baseline and 272 events in men without a history of heart disease.
Two controls per case were selected by individual matching.
Results Among men with known heart disease at baseline, the relative risk (95%
confidence interval) of CHD events adjusted for age, smoking, hypertension,
diabetes mellitus, serum cholesterol level, body mass index, and alcohol consumption
was 2.23 (95% confidence interval, 1.03-4.85) in the highest serum homocysteine
quintile compared with the lowest quintile. Among the men free of heart disease
at baseline, the corresponding relative risk was 0.90 (95% confidence interval,
0.51-1.60).
Conclusions This prospective study does not support the hypothesis that a high concentration
of serum homocysteine is a risk factor for coronary events in a population
free of heart disease. However, it does suggest that mild hyperhomocystinemia
predicts secondary coronary events in men with heart disease, possibly as
a consequence of atherosclerotic changes.
From the National Public Health Institute, Helsinki, Finland (Drs Knekt,
Reunanen, Alfthan, Heliövaara, and Aromaa and Mr Rissanen); and the Social
Insurance Institution, Turku, Finland (Dr Marniemi).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Is Hyperhomocysteinemia a Risk Factor or a Consequence of Coronary Heart Disease?
Marco Cattaneo, Paul Knekt, Antti Reunanen, Georg Alfthan, Markku Heliövaara, Harri Rissanen, Jukka Marniemi, and Arpo Aromaa
Arch Intern Med. 2001;161(21):2628-2629.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2001;161(13):1683-1684.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand et al.
ANN INTERN MED 2009;151:496-507.
ABSTRACT
| FULL TEXT
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Humphrey et al.
Mayo Clin Proc. 2008;83:1203-1212.
ABSTRACT
| FULL TEXT
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients
Akalin et al.
Eur J Endocrinol 2008;158:47-52.
ABSTRACT
| FULL TEXT
Relationship Between Homocysteine and Mortality in Chronic Kidney Disease
Menon et al.
Circulation 2006;113:1572-1577.
ABSTRACT
| FULL TEXT
Fractions of Total Plasma Homocysteine in Patients with Ischemic Stroke Before the Age of 55 Years
Sobol et al.
ANGIOLOGY 2005;56:201-209.
ABSTRACT
Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C->T mutation on homocysteine concentrations in healthy adults: the ATTICA Study
Dedoussis et al.
Am. J. Clin. Nutr. 2004;80:849-854.
ABSTRACT
| FULL TEXT
Antibodies to Periodontal Pathogens and Stroke Risk
Pussinen et al.
Stroke 2004;35:2020-2023.
ABSTRACT
| FULL TEXT
The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study
Chrysohoou et al.
Vasc Med 2004;9:117-123.
ABSTRACT
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction
Moridani
Clin. Chem. 2004;50:782-784.
FULL TEXT
Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus
Soinio et al.
ANN INTERN MED 2004;140:94-100.
ABSTRACT
| FULL TEXT
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction
Infante-Rivard et al.
Clin. Chem. 2003;49:1476-1482.
ABSTRACT
| FULL TEXT
Lack of association between early atherosclerotic carotid artery wall lesions and serum level of homocysteine
Rajala et al.
British Journal of Diabetes & Vascular Disease 2003;3:230-232.
ABSTRACT
Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease
De Bree et al.
Pharmacol. Rev. 2002;54:599-618.
ABSTRACT
| FULL TEXT
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects
De Bree et al.
Int J Epidemiol 2002;31:1268-1272.
FULL TEXT
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration
JAMA 2002;288:2015-2022.
ABSTRACT
| FULL TEXT
Plasma Homocysteine and Parental Myocardial Infarction in Young Adults in Jerusalem
Kark et al.
Circulation 2002;105:2725-2729.
ABSTRACT
| FULL TEXT
Plasma Homocysteine Is not Increased in Microalbuminuric Patients With Type 2 Diabetes Without Clinical Cardiovascular Disease
Gonzalez-Clemente et al.
Diabetes Care 2002;25:632-633.
FULL TEXT
Methylmalonic Acid and Clinical Practice
Aguirre et al.
Arch Intern Med 2002;162:102-103.
FULL TEXT
Is Hyperhomocysteinemia a Risk Factor or a Consequence of Coronary Heart Disease?
Cattaneo et al.
Arch Intern Med 2001;161:2628-2629.
FULL TEXT
|
